Related Experiment Video
Updated: Oct 14, 2025

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Obesity and Nonalcoholic Fatty Liver Disease
1Department of Transplant, Mayo Clinic College of Medicine, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
Obesity and nonalcoholic fatty liver disease (NAFLD) are global health issues. Current treatments focus on lifestyle changes, with future therapies potentially including new drugs.
Area of Science:
- Hepatology
- Endocrinology
- Public Health
Background:
- Obesity and nonalcoholic fatty liver disease (NAFLD) present significant global health challenges.
- Complications of these conditions are increasingly leading to primary care visits and hospitalizations.
Purpose of the Study:
- To provide a comprehensive overview of obesity and NAFLD.
- To discuss the pathogenesis, clinical presentation, and diagnostic criteria for NAFLD and nonalcoholic steatohepatitis (NASH).
- To review current practice guidelines for NAFLD management.
Main Methods:
- Literature review of NAFLD and obesity.
- Overview of NAFLD pathogenesis and clinical aspects.
- Review of established practice guidelines.
Main Results:
- NAFLD and obesity are prevalent conditions with serious complications.
- Current treatment primarily involves lifestyle modifications (diet, exercise, behavior change).
- Emerging drug therapies show promise for future NAFLD treatment.
Conclusions:
- Lifestyle modifications remain the cornerstone of NAFLD management.
- Further research is essential to advance novel therapeutic strategies for NAFLD.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Drug Dosing: Obese Patients